Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

NCT00527982 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Termination due to poor accrual.

Conditions

Head and Neck Cancer
Lung Cancer

Interventions

DRUG: Celecoxib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]